Camlin Fine
Camlin Fine Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Vanillin sales expected to reach about 4,000 tons next year. The company expects 20% growth in the Blends business next year, supported by a 20% increase in salesforce and inorganic growth from acquisitions.
From Camlin Fine's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Vanillin sales expected to reach about 4,000 tons next year.
- Blends business targeted to grow by 20% next year.
- Overall blends business projected to grow by 18%-20% year-on-year, supported by field force expansion and inorganic growth (new acquisition in France).
- Field force expanded by 21%, with impact expected to start from Q4 FY'26 and continue into next year.
- Incremental EBITDA expected from diphenol facility ramp-up, currently at ~50%-55% utilization, aiming for full capacity with cost advantages.
- Sales growth for blends and vanillin on track despite tariff pressures and global uncertainties.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Camlin Fine said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No significant fixed asset expenditure apart from maintenance-related spends in the recent period.
- Gross debt situation has remained stable, with some loan repayments balanced by working capital needs due to revenue growth.
- Growth-related debt is expected to remain at the same level going forward.
- Management highlighted ongoing additions of field force and potential inorganic growth through acquisitions (e.g., acquisition in France to become a subsidiary this quarter) to support blended business growth.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Camlin Fine said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Specific details regarding the current or expected order book or pending orders for Camlin Fine Sciences Limited were not explicitly disclosed during the call.
- Contracts for Vanillin for H1 calendar year 2027 have been signed, indicating some visibility into the near-term order book at prevailing prices (around $19.5 DDP).
- Contracts are generally for one or two quarters rather than full-year contracts due to current market uncertainties and existing channel stocks.
- The company noted winning some contracts for the first half of next year, reflecting a moderate order pipeline amid tariff and market challenges.
- Demand is cautiously monitored given over-inventories in US and Europe; full clarity awaits tariff resolution and inventory normalization.
2 more points management made on order book & pipeline
Camlin Fine — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹425 Cr, net profit ₹86 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Camlin Fine's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Bodal Chemicals Ltd (Q2 FY26)
Q2 FY26 consolidated revenue from operations: Rs 4,804.5 mn, up 11.2% YoY from Rs 4,321.2 mn (Page 10). Key concall takeaways from Bodal Chemicals Ltd's Q2…
- Chemcon Speciality Chemicals Ltd (Q2 FY26)
Q2 FY26 revenue from operations: ₹53.7 crore, up 2% YoY (vs ₹52.6 crore in Q2 FY25) [Page 9, 6] . Key concall takeaways from Chemcon Speciality Chemicals Ltd's…
- Valiant Organics Ltd (Q2 FY26)
Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Key concall takeaways from Valiant Organics Ltd's Q2 FY26…
- Indian Phosphate Ltd (Q2 FY26)
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…
Frequently Asked Questions
What were Camlin Fine Q2 FY26 results?
Vanillin sales expected to reach about 4,000 tons next year. The company expects 20% growth in the Blends business next year, supported by a 20% increase in salesforce and inorganic growth from acquisitions.
What is Camlin Fine share price analysis?
Camlin Fine currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,993 Cr. Investors should review the full earnings analysis for detailed insights.
Is Camlin Fine planning capital expenditure?
No significant fixed asset expenditure apart from maintenance-related spends in the recent period. - Gross debt situation has remained stable, with some loan repayments balanced by working capital needs due to revenue growth. - Growth-related debt is expected to remain at the same level going forward. - Management highlighted ongoing additions of field force and potential inorganic growth through acquisitions (e.g., acquisition in France to become a subsidiary this quarter) to support blended business growth. - No explicit mention of large-scale future capital investment projects was made in the transcript.
Keep Camlin Fine on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.